A groundbreaking trial will see healthy adults across Britain with no signs of memory loss given an Alzheimer's drug in an attempt to prevent the condition developing

The first participants in Europe will be screened in Britain from Monday, with more than 15 UK centres expected to take part in the global study.

Healthy middle-aged people deemed to be at higher risk of developing condition among those eligible to participate